CUV 1.00% $14.10 clinuvel pharmaceuticals limited

Ann: Change of Director's Interest Notice, page-18

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 7,705 Posts.
    lightbulb Created with Sketch. 2797
    People don't like the truth.

    The only thing CUV has achieved is getting a 40 year old patent-expired drug approved for a rare disease. It took them a decade to achieve that relatively simple task, Yet posters spam the forum non-stop with rubbish about a series blockbuster drugs that are 'certainties' to be approved in the near future.The reality is more like 3-5 years with a 5-10% chance of success.

    If the prospects are so good why are directors selling their shares? It defies logic.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.